CCND1 and cholangiocarcinoma: Tyrphostin AG1517 and tyrphostin AG879 as inhibitors of EGFR and ERBB2, respectively, effectively suppress the growth of CC cells, and combination treatment has shown a synergistic effect on the inhibition of CC cell growth by inhibiting cyclin D1 and activating caspase-3 [41].